癌診療指針のための病理診断プラクティス　乳癌

出版社： 中山書店
著者：
発行日： 2011-09-20
分野： 臨床医学：一般  >  癌/腫瘍一般
ISBN： 9784521733340
シリーズ： 癌診療指針のための病理診断プラクティス
電子書籍版： 2011-09-20 （初版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

19,800 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

19,800 円(税込)

購入する

商品紹介

腫瘍の診断において中心的役割をつとめる病理診断は，画像医学の進歩とともにその重要性を増している。本書では，病理医，臨床医が互いに理解を深められるよう，病理診断の基本を解説。また，鑑別診断の章では疾患別にフローチャートを用意して，鑑別すべき病理像も豊富に掲載し，病理医だけでなく，臨床医にも活用しやすい，実用のための書籍となっている。

目次

  • 癌診療指針のための病理診断プラクティス　乳癌

    ―目次―

    1章　病理診断の流れとポイント
    　乳腺疾患の病理診断

    2章　診断のための基本知識
    　細胞診と針生検
    　　細胞診と針生検の使い分け
    　　細胞診の有用性と問題点
    　　針生検標本の病理診断
    　画像診断法
    　免疫組織診断とsubtype分類
    　分子生物学的な予後予測
    　薬物療法のガイドライン
    　乳癌の手術療法
    　　乳房温存療法と予後
    　　乳房温存手術切除標本の断端判定
    　センチネルリンパ節生検
    　　概念と手技
    　　センチネルリンパ節の転移診断
    　術前療法
    　　術前療法の意義
    　　術前療法の組織学的効果判定

    3章　乳腺疾患の概要と鑑別診断
    　上皮性腫瘍―癌および境界病変
    　　浸潤性乳管癌
    　　浸潤性小葉癌
    　　管状癌
    　　髄様癌
    　　粘液癌
    　　神経内分泌癌
    　　浸潤性微小乳頭癌
    　　アポクリン癌
    　　化生癌
    　　分泌癌
    　　腺様嚢胞癌
    　　glycogen-rich明細胞癌
    　　非浸潤性乳管癌
    　　小葉性腫瘍
    　　乳管過形成
    　　異型乳管過形成
    　　乳管内乳頭状病変
    　上皮性腫瘍―特殊な癌
    　　炎症性乳癌
    　　Paget病
    　　男子乳癌
    　良性上皮増殖性病変
    　　腺症
    　　硬化性瘢痕
    　関連腫瘍性病変
    　　乳管腺腫
    　　乳頭部腺腫
    　　管状腺腫
    　　腺筋上皮腫
    　　線維腺腫
    　　葉状腫瘍
    　　顆粒細胞腫
    　　過誤腫
    　　血管肉腫
    　　悪性リンパ腫
    　非腫瘍性病変
    　　女性化乳房症
    　　副乳
    　　糖尿病性乳腺症
    　　結節性筋膜炎

    4章　病理検体の取り扱い
    　切り出し方法
    　病理報告書作成

    5章　症例の実際
    　症例1　異型を示す乳管内増殖性病変
    　症例2　偽浸潤像を示す病変
    　症例3　細胞質に微細顆粒がみられる腫瘍
    　症例4　乳頭に発生した腫瘍

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

1章 病理診断の流れとポイント

P.2 掲載の参考文献
日本乳癌学会編. 乳腺腫瘍の組織学的分類. 臨床・病理乳癌取扱い規約. 第16版. 東京 : 金原出版 ; 2008.
 
Rosen PP, Oberman HA. Tumors of the mammary gland. Atlas of tumor pathology. Washington : AFPI ; 1993.
 
World Health Organization. Pathology & genetics. Tumours of the breast and female genital organs. In : Tavassoli A, Devilee P, editors. Lyon : WHO ; 2003.
 
Rosen PP. Fibroepithelial neoplasms ; Rosen's breast pathology. Phildelphia : Lippincott Williams & Wilkins ; 2001, 163-76.
 
Haagensen CD. Fibrous disease of the breast. 3rd ed. Philadelphia : Saunders ; 1986, 125-35.
 

2章 診断のための基本知識

P.17 掲載の参考文献
土屋眞一, 秋山太ほか編. 乳腺病理カラーアトラス. 細胞診. 東京 : 文光堂 ; 2008. p.16-23.
 
土屋眞一, 秋山太ほか編. 乳腺針生検病理診断アトラス. 針生検を依頼すべき細胞像. 東京 : 文光堂 ; 2009. p.18-9.
 
土屋眞一編. 乳腺細胞診カラーアトラス. 東京 : 医療科学社 ; 2007. p.71-84.
 
P.26 掲載の参考文献
Leifland K, Lundquist H, et al. Comparison of stereotactic fine needle aspiration biopsy and core needle biopsy in 522 non-palpable breast carcinoma. Acta Radiol. 2003 ; 44 : 387-91.
 
Denisson G, Anand R, et al. A prospective study of the use of fine-needle aspiration cytology and core biopsy in diagnosis of breast cancer. Breast J. 2003 ; 9 : 491-3.
 
P.31 掲載の参考文献
日本医学放射線学会, 日本放射線技術学会編. マンモグラフィガイドライン. 東京 : 医学書院 ; 2010.
 
日本乳腺甲状腺超音波診断会議編. 乳房超音波診断ガイドライン. 東京 : 南江堂 ; 2008.
 
Yuen S, et al. Breast carcinomas with strong high-signal intensity on T2-weighted MR images : pathological characteristics and differential diagnosis. J Magn Reson Imaging. 2007 ; 25 (3) : 502-10.
PubMed
Uematsu T, et al. Triple-negative breast cancer : correlation between MR imaging and pathologic findings. Radiology. 2009 ; 250 (3) : 638-47.
PubMed
Weinstein S, Rosen M. Breast MR imaging : current indications and advanced imaging techniques. Radiol Clin North Am. 2010 ; 48 (5) : 1013-42.
PubMed
Uematsu T, et al. Neoadjuvant chemotherapy for breast cancer : correlation between the baseline MR imaging findings and responses to therapy. Eur Radiol. 2010 ; 20 (10) : 2315-22.
PubMed
Uematsu T, et al. Comparison of magnetic resonance imaging, maltidetector row computed tomography, ultrasonography, and mammography for tumor extension of breast cancer. Breast Cancer Res Treast 2008 ; 112 (3) : 461-74.
PubMed
P.38 掲載の参考文献
Perou CM, Sorlie T, et al. Molecular portraits of human breast tumours. Nature. 2000 ; 406 : 747-52.
PubMed
Sorlie T, Peou CM, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA. 2001 ; 98 : 10869-74.
 
Sorlie T, Tibshirani R, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA. 2003 ; 100 : 8418-23.
PubMed
Carey LA, Perou CM, et al. Race, breast cancer sub types, and survival in the Carolina breast cancer study. JAMA. 2006 ; 296 : 2492-502.
 
Kurosumi M. Immunohistochemical assessment of hormone receptor status using a new scoring system (J-Score) in breast cancer. Breast Cancer. 2007 ; 14 : 189-93.
PubMed
Rakha EA, Reis-Filho JS, et al. Basal-like breast cancer. A critical review. 2008 ; JCO. 26 : 2568-81.
 
P.44 掲載の参考文献
van't Veer LJ, Dai H, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature. 2002 ; 31 ; 415 (6871) : 530-6.
 
van de Vijver MJ, He YD, et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med. 2002 ; 19 ; 347 (25) : 1999-2009.
 
Buyse M, Loi S, et al. TRANSBIG Consortium. Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer. J Natl Cancer Inst. 2006 ; 6 ; 98 (17) : 1183-92.
PubMed
Wittner BS, Sgroi DC, et al. Analysis of the MammaPrint breast cancer assay in a predominantly postmenopausal cohort. Clin Cancer Res. 2008 ; 15 ; 14 (10) : 2988-93.
 
Bueno-de-Mesquita JM, Linn SC, et al. Validation of 70-gene prognosis signature in nodenegative breast cancer. Breast Cancer Res Treat. 2009 ; 117 (3) : 483-95. Epub 2008 Sep 26.
 
Ishitobi M, Goranova TE, et al. Clinical utility of the 70-gene MammaPrint profile in a Japanese population. Jpn J Clin Oncol. 2010 ; 40 (6) : 508-12. Epub 2010 Jan 27.
 
Paik S, Shak S, et al. A multigene assay to predict recurrence of tamoxifen-treated, nodenegative breast cancer. N Engl J Med. 2004 ; 30 ; 351 (27) : 2817-26. Epub 2004 Dec 10.
 
Toi M, Iwata H, et al. Clinical significance of the 21-gene signature (Oncotype DX) in hormone receptor-positive early stage primary breast cancer in the Japanese population. Cancer. 2010 ; 1 ; 116 (13) : 3112-8.
PubMed
Sotiriou C, Wirapati P, et al. Gene expression profiling in breast cancer : understanding the molecular basis of histologic grade to improve prognosis. J Natl Cancer Inst. 2006 ; 15 ; 98 (4) : 262-72.
 
Naoi Y, Kishi K, et al. High genomic grade index associated with poor prognosis for lymph node-negative and estrogen receptor-positive breast cancers and with good response to chemotherapy. Cancer. 2011 ; 117 (3) : 472-9
PubMed
Naoi Y, Kishi K, et al. Development of 95-gene classifier as a powerful predictor of recurrences in node-negative and ER-positive breast cancer patients. Breast Cancer Res Treat. 2011 ; 128 (3) : 633-41.
PubMed
Schmidt M, Bohm D, et al. The humoral immune system has a key prognostic impact in node-negative breast cancer. Cancer Res. 2008 ; 1 ; 68 (13) : 5405-13.
 
P.50 掲載の参考文献
UpToDate http://www.uptodate.com/
 
NCCN Clinical Practice Guidelines in Oncology http://www.nccn.org/index.asp
 
日本乳がん情報ネットワーク http://www7a.biglobe.ne.jp/~jccnb/
 
Goldhirsch A, et al. Thresholds for therapies : highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer. Ann Oncol. 2009 ; 20 : 1319-29.
PubMed
NPO法人 がん情報局 http://www.ganjoho.org/
 
American Society of Clinical Oncology http://www.asco.org/
 
Hammond ME, et al. American society of clinical oncology/college of american pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol. 2010 ; 28 : 2784-95.
 
Burstein HJ, et al. American Society of Clinical Oncology clinical practice guideline : Update on Adjuvant Endocrine Therapy for Women with Hormone Receptor-Positive Breast Cancer. J Clin Oncol. 2010 ; 28 : 3784-96.
 
National Cancer Institute http://www.cancer.gov/cancertopics/pdq
 
癌情報サイト Cancer Information Japan http://cancerinfo.tri-kobe.org/
 
日本乳癌学会編. 乳癌診療ガイドライン 1. 薬物療法 2010年版. 東京 : 金原出版 ; 2010.
 
P.56 掲載の参考文献
日本乳癌学会学術委員会作成. 乳房温存療法ガイドライン. 1999.
 
Sanghani M, Truong PT, et al. Validation of a web-based predictive nomogram for ipsilateral breast tumor recurrence after breast conserving therapy. J Clin Oncol. 2010 ; 28 : 718-22.
PubMed
Huang E, Buchholz TA, et al. Classifying local disease recurrences after breast conservation therapy based on location and histology : new primary tumors have more favorable outcomes than true local disease recurrences. Cancer. 2002 ; 95 : 2059-67.
PubMed
Komoike Y, Akiyama F, et al. Analysis of ipsilateral breast tumor recurrences after breast-conserving treatment based on the classification of true recurrences and new primary tumors. Breast Cancer. 2005 ; 12 : 104-11.
PubMed
Vicini FA, Goldstein NS, et al. Molecular evidence demonstrating local treatment failure is the source of distant metastases in some patients treated for breast cancer. Int J Radiat Oncol Biol Phys. 2008 ; 71 : 689-94.
PubMed
Tasevski R, Gogos AJ, et al. Reoperative sentinel lymph node biopsy in ipsilateral breast cancer relapse. Breast. 2009 ; 18 : 322-6.
PubMed
Silverstein MJ, Lagios MD, et al. A prognostic index for ductal carcinoma in situ of the breast. Cancer. 1996 ; 77 : 2267-74.
PubMed
Pierce LJ, Levin AM, et al. Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancer. J Clin Oncol. 2006 ; 24 : 2437-43.
 
Rastogi P, Anderson SJ, et al. Preoperative chemotherapy : updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27. J Clin Oncol. 2008 ; 26 : 778-85.
 
Cebrecos I, Cordoba O, et al. Can we predict local recurrence in breast conserving surgery after neoadjuvant chemotherapy? Eur J Surg Oncol. 2010 ; 36 : 528-34.
PubMed
P.63 掲載の参考文献
Heimann R, Powers C, et al. Breast preservation in stage I and II carcinoma of the breast. The University of Chicago experience. Cancer. 1996 ; 78 : 1722-30.
 
Clarke M, Collins R, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival : an overview of the randomised trials. Lancet. 2005 ; 366 : 2087-106.
PubMed
Fortin A, Larochelle M, et al. Local failure is responsible for the decrease in survival for patients with breast cancer treated with conservative surgery and postoperative radiotherapy. J Clin Oncol. 1999 ; 17 : 101-9.
PubMed
Cox CE, Ku NN, et al. Touch preparation cytology of breast lumpectomy margins with histologic correlation. Arch Surg. 1991 ; 126 : 490-3.
PubMed
Klimberg VS, Harms S, et al. Assessing margin status. Surg Oncol. 1999 ; 8 : 77-84.
PubMed
Creager AJ, Shaw JA, et al. Intraoperative evaluation of lumpectomy margins by imprint cytology with histologic correlation : a community hospital experience. Arch Pathol Lab Med. 2002 ; 126 : 846-8.
PubMed
Cox CE, Pendas S, et al. Local recurrence of breast cancer after cytological evaluation of lumpectomy margins. Am Surg. 1998 ; 64 : 533-7, discussion 537-8.
 
Carter D. Margins of "lumpectomy" for breast cancer. Hum Pathol. 1986 ; 17 : 330-2.
PubMed
Gibson GR, Lesnikoski BA, et al. A comparison of ink-directed and traditional whole-cavity re-excision for breast lumpectomy specimens with positive margins. Ann Surg Oncol. 2001 ; 8 : 693-704.
PubMed
黒住昌史, 坂元吾偉ほか. IV 病理検索. 厚生労働科学研究費補助金「がん臨床研究事業」標準的な乳房温存療法の実施要項の研究班編. 乳房温存療法ガイドライン. 東京 : 金原出版 ; 2005 : 22-6.
 
Rosen PP. Pathologic examination of breast and lymph node specimens, including sentinel lymph nodes. In : Rosen's Breast Pathology, third edition. Philadelphia : Lippincott Williams & Wilkins, a Wolters Kluwer business ; 2009. p.1034-52.
 
矢形寛, 芳賀駿介ほか. 整容性からみた乳房温存治療ハンドブック. 東京 : メディカル・サイエンス・インターナショナル ; 2010.
 
堀井理絵, 秋山太. 乳癌 I-乳腺病理診断の実際-断端の診断. 病理と臨床. 東京 : 文光堂 ; 2008 ; 26 : 1042-6.
 
P.68 掲載の参考文献
Cox CE. Lymphatic mapping in breast cancer : combination technique. Ann Surg Oncol. 2001 ; 8 : 67-70.
 
Cody HS III. Clinical aspects of sentinel node biopsy. Breast Cancer Res. 2001 ; 3 : 104-8.
 
Kim T, et al. Lymphatic mapping and sentinel lymph node biopsy in early stage breast carcinoma : a metaanalysis. Cancer. 2006 ; 106 : 4-16.
PubMed
Krag DN, et al. Sentinel-lymph-node resection compared with conventional axillary-lymphnode dissection in clinically node-negative patients with breast cancer : overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 2010 ; 11 : 927-33.
PubMed
Lyman GH, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol. 2005 ; 23 : 7703-20.
 
Krag DN, et al. National surgical adjuvant breast and bowel project, technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer : results from the NSABP B-32 randomised phase III trial. Lancet Oncol. 2007 ; 8 : 881-8.
PubMed
Kurosumi M, et al. Significance and problems of histopathological examination and utility of real-time reverse transcriptase-polymerase chain reaction method for the detection of sentinel lymph node metastasis in breast cancer. Breast Cancer. 2007 ; 14 : 342-9.
PubMed
Giuliano AE, et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases. The American College of Surgeons Oncology Group Z0011 Randomized Trial. Ann Surg. 2010 ; 252 : 426-33.
 
Kelly AM, et al. Breast cancer sentinel node identification and classification after neoadjuvant chemotherapy-systematic review and meta analysis. Acad Radiol. 2009 ; 16 : 551-63.
PubMed
P.73 掲載の参考文献
Krag DN, Weaver OJ, et al. Surgical resection and radiolocalization of the sentinel node in breast cancer using a gamma probe. Surg Oncol. 1993 ; 2 : 335-40.
 
Giuliano AE, Kirgan DM, et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 1994 ; 220 : 391-401.
PubMed
European Working Group for Breast Screening Pathology : Pathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines. Eur J Cancer. 2003 ; 39 : 1654-67.
 
Veronesi U, Paganelli G, et al. Sentinel-lymph-node biopsy as a staging procedure in breast cancer : update of a ramdomized controlled study. Lancet Oncol. 2006 ; 7 : 983-90.
 
International Agency for Research on Cancer (IARC). WHO histological classification of tumours of the breast. World Health Organization Classification of Tumours, Pathology & Genetics, Tumours of the Breast and Female Genital Organs. In : Tavassoli FA, Devilee P, editors. Lyon : IARC Press. 2003 ; 10-2.
 
Schwartz GF, Giuliano AE, et al. Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19-22, 2001,Philadelphia, Pensylvania. Cancer. 2002 ; 94 : 2542-51.
 
Lambert LA, Ayers GD, et al. Validation of a breast cancer nomogram for predicting nonsentinel lymph node metastases after a positive sentinel node biopsy. Ann Surg Oncol. 2006 ; 13 : 310-20.
PubMed
P.78 掲載の参考文献
Clarke M, Coates AS, et al. Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer : patient-level meta-analysis of randomised trials. Lancet. 2008 ; 371 (9606) : 29-40.
PubMed
Fisher B, Bryant J, et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol. 1998 ; 16 (8) : 2672-85.
PubMed
Smith IC, Heys SD, et al. Neoadjuvant chemotherapy in breast cancer : significantly enhanced response with docetaxel. J Clin Oncol. 2002 ; 20 (6) : 1456-66.
PubMed
Dowsett M, Dunbier A, et al. Biomarkers and predictive factors of response to neoadjuvant treatment. Breast Cancer Res. 2009 ; 11 (Suppl 1) : S11.
 
Gianni L, Eiermann W, et al. Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial) : a randomised controlled superiority trial with a parallel HER2-negative cohort. Lancet. 2010 ; 375 (9712) : 377-84.
 
Beselga J, et al. First results of the NeoALTTO trial (BIG01-06/EGF 106903) : a phase III, randomized, open label, neoadjuvant study of Lapatinib, Trastuzumab, and their combination plus Paclitaxel in women with HER2-positive primary breast cancer. Cancer Research. 2010 ; 70 (24 Suppl.) 82s.
 
Baselga J, Semiglazov V, et al. Phase II randomized study of neoadjuvant everolimus plus letrozole compared with placebo plus letrozole in patients with estrogen receptor-positive breast cancer. J Clin Oncol. 2009 ; 27 (16) : 2630-7.
PubMed
Venturini M, et al. Open-label phase II study of neoadjuvant bevacizumab combined with FEC → paclitaxel in patients with inflammatory or locally advanced breast cancer, Cancer Research. 2010 ; 70 (24 Suppl.) 172s.
 
Carpenter JT, et al. Concurrent and sequential Bevacizumab and preoperative chemotherapy in the treatment of locally advanced breast cancer : UAB 0493, Cancer Research. 2010 ; 70 (24 Suppl.) 173s
 
Dose-Schwarz J, Tiling R, et al. Assessment of residual tumour by FDG-PET : conventional imaging and clinical examination following primary chemotherapy of large and locally advanced breast cancer. Br J Cancer. 2010 ; 102 (1) : 35-41.
PubMed
P.83 掲載の参考文献
Fisher B, Brown A, et al. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer : Findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol. 1997 ; 15 : 2483-93.
PubMed
Heys SD, Hutcheon AW, et al. Aberdeen Breast Group : Neoadjuvant docetaxel in breast cancer : 3-year survival results from the Aberdeen trial. Clin Breast Cancer. 2002 ; 2 : S69-74.
 
Bear HD, Anderson S, et al. National Surgical Adjuvant Breast and Bowel Project Protocol B-27 : The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide : preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol. 2003 ; 21 : 4165-74.
PubMed

3章 乳腺疾患の概要と鑑別診断

P.88 掲載の参考文献
Stuart JS, Laura CC. Biopsy Interpretation of the Breast. Philadelphia : Lippincott Williams & Wilkins, a Wolters Lluwer business ; 2009.
 
Fattaneh AT, Vincenzo E. Tumors of the Mammary Gland. Washington ; American Registry of Pathology ; 2009.
 
市原周. 乳腺病理学-細胞・組織・画像-. 愛知 : 名古屋大学出版会 ; 2000.
 
NHS Breast Screening Programme. Pathology Reporting of Breast Disease. The Royal College of Pathologists Cancer Screening Programmes. NHSBSP Publication No.58. 2005.
 
Ian E, Laura C, et al. Ductal carcinoma NOS and variants in WHO Classification of Tumours of the Breast. 4th ed. IARC (in press).
 
Badve S, Dabbs DJ, et al. Basal-like and triple-negative breast cancers : a critical review with an emphasis on the implications for pathologists and oncologists. Mod Pathol. 2010 ; 12.
 
Rakha EA, Reis-Filho JS, et al. Breast cancer prognostic classification in the molecular era : the role of histological grade.Breast Cancer Res. 2010 ; 12 (4) : 207. Epub 2010.
 
Farid M. Essentials of Diagnostic Breast Pathology. Berlin : Springer-Verlag ; 2007.
 
P.102 掲載の参考文献
Tavassoli FA, Devilee P, editors. Pathology and Genetics, Tumours of the Breast and Female Genital Organs. Lyon ; IARC Press ; 2003.
 
Tavassoli FA, Eusebi V. Afip Atlas of Tumor Pathology. Fourth Series Fascicle 10. Tumors of the Mammary Gland. 2009.
 
Rosen PP. Rosen's Breast Pathology. 3rd ed. Philadelphia ; Lippincott Wiliams & Wilkins ; 2009.
 
Rosen PP. Columnar cell hyperplasia is associated with lobular carcinoma in situ and tubular carcinoma. Am J Surg Pathol. 1999 ; 23 : 1561.
PubMed
Brandt SM, Young GQ, et al. The "Rosen Triad" : tubular carcinoma, lobular carcinoma in situ, and columnar cell lesions. Adv Anat Pathol. 2008 ; 15 : 140-6. Review.
PubMed
Abdel-Fatah TM, Powe DG, et al. High frequency of coexistence of columnar cell lesions, lobular neoplasia, and low grade ductal carcinoma in situ with invasive tubular carcinoma and invasive lobular carcinoma. Am J Surg Pathol, 2007 ; 31 ; 417-26.
PubMed
Haupt B, Schwartz MR, et al. Columnar cell lesions : a consensus study among pathology trainees. Hum Pathol. 2010 ; 41 : 895-901.
PubMed
P.107 掲載の参考文献
Rosen PP. Medullary carcinoma. In : Rosen PP, editor. Rosen's Breast Pathology. 3rd ed. Philadelphia : Lippincott Williams&Wilkins, a Wolter Kluwer business ; 2009. p.449-69.
 
Eusebi V, Mai KT, Taranger-Charpin A. Tumours of thenipple. In : Tavassoli FA, Devilee P, editors. World Health Organization Classification of Tumours. Pathology & Genetics Tumours of the Breast and Female Genital Organs. Lyon : IARC Press ; 2003. p.104-6.
 
P.112 掲載の参考文献
日本乳癌学会編. 臨床・病理乳癌取扱い規約. 第16版. 東京 : 金原出版 ; 2008. p.29.
 
佐藤尚紀ほか. 乳腺粘液癌症例の臨床病理学的検討. 乳癌の臨床. 1993 ; 8 (2) : 249-54.
Medical*Online
Komaki K, et al. Mucinous carcinoma of the breast in Japan. A prognostic analysis based on morphologic features. Cancer. 1988 ; 61 (5) : 989-96.
PubMed
塩澤幹雄ほか. 粘液癌の術式について 郭清の省略と温存術に関する自験例46例からの検討. 乳癌の臨床. 2006 ; 21 (5) : 467-73.
Medical*Online
Toikkanen S, Kujari, H. Pure and mixed mucinous carcinomas of the breast : a clinicopathologic analysis of 61 cases with long-term follow-up. Hum Pathol, 1989 ; 20 (8) : 758-64.
PubMed
Ranade A, et al. Clinicopathological evaluation of 100 cases of mucinous carcinoma of breast with emphasis on axillary staging and special reference to a micropapillary pattern. J Clin Pathol. 2010 ; 63 (12) : 1043-7.
PubMed
Capella C, et al. Endocrine differentiation in mucoid carcinoma of the breast. Histopathology. 1980 ; 4 (6) : 613-30.
PubMed
Cross AS, et al. A morphological and immunocytochemical study of a distinctive variant of ductal carcinoma in-situ of the breast. Histopathology, 1985 ; 9 (1) : 21-37.
PubMed
Tsang WY, Chan JK. Endocrine ductal carcinoma in situ (E-DCIS) of the breast : a form of low-grade DCIS with distinctive clinicopathologic and biologic characteristics. Am J Surg Pathol. 1996 ; 20 (8) : 921-43.
PubMed
Tajima S, et al. Evaluation of CD56 and CD57 immunostainings for discrimination between endocrine ductal carcinoma in situ and intraductal papilloma. Pathol Int. 2010 ; 60 (6) : 459-65.
PubMed
土屋眞一監. 新版 乳腺細胞診カラーアトラス. 東京 : 医療科学社 ; 2007. p.192-3.
 
Tavassoli F, Devilee P. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. World Health Organization Classification of Tumours. Lyon : IARC Press ; 2003.
 
Yamaguchi R. Cytological features of myxomatous fibroadenoma of the breast. Diagn Cytopathol. 2010. (in press).
 
P.117 掲載の参考文献
Ellis IO, et al. Invasive Breast Carcinoma. In : Tavassoli FA, Devilee P, editors. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon : IARC Press ; 2003. p.13-59.
 
Righi L, et al. Neuroendocrine differentiation in breast cancer : established facts and unresolved problems. Semin Diagn Pathol. 2010 ; 27 : 69-76.
PubMed
日本乳癌学会編 : 臨床・病理乳癌取扱い規約. 第16版. 東京 : 金原出版 ; 2008. p.18-59.
 
Cubilla AL, Woodruff JM. Primary carcinoid tumor of the breast : A report of eight patients. Am J Surg Pathol. 1977 ; 1 : 283-92.
 
Kawasaki T, et al. Neuroendocrine ductal carcinoma in situ (NE-DCIS) of the breastcomparative clinicopathological study of 20 NE-DCIS cases and 274 non-NE-DCIS cases. Histopathology. 2008 ; 53 : 288-98.
PubMed
Wei B, et al. Invasive neuroendocrine carcinoma of the breast : a distinctive subtype of aggressive mammary carcinoma. Cancer. 2010 ; 116 : 4463-73.
PubMed
Sapino A, et al. Diagnostic cytological features of neuroendocrine differentiated carcinoma of the breast. Virchows Arch. 1998 ; 433 : 217-22. Review.
PubMed
Shin SJ, et al. Small cell carcinoma of the breast : a clinicopathologic and immunohistochemical study of nine patients. Am J Surg Pathol. 2000 ; 24 : 1231-8.
PubMed
Capella C, et al. Endocrine differentiation in mucoid carcinoma of the breast. Histopathology. 1980 ; 4 : 613-30.
PubMed
Weigelt B, et al. Mucinous and neuroendocrine breast carcinomas are transcriptionally distinct from invasive ductal carcinomas of no special type. Mod Pathol. 2009 ; 22 : 1401-14.
PubMed
P.128 掲載の参考文献
Rosen PP. Invasive micropapillary carcinoma. In : Rosen PP, editor. Rosen's Breast Pathology. 3rd ed. Philadelphia : Lippincott Williams&Wilkins, a Wolter Kluwer business ; 2009. p.616-20.
 
Ellis IO, Schnitt SJ, Sastre-Garau X, et al. Invasive breast carcinoma. In : Tavassoli FA, Devilee P. editors, World Health Organization Classification of Tumours. Pathology & Genetics Tumours of the Breast and Female Genital Organs. Lyon : IARC Press ; 2003. p.13-59.
 
Ide Y, Horii R, Osako T, et al. Clinicopathological significance of invasive micropapillary carcinoma of the breast. Pathol Int, in submitted.
 
P.135 掲載の参考文献
Tavassoli FA, et al. Invasive breast carcinoma. In : Tavassoli FA, Devilee P, editors. World Health Organization Classification of Tumours. Pathology and Genetics. Tumours of the Breast and Female Genital Organs. Lyon : IARC Press ; 2003. p.36-7.
 
Rosen PP. Apocrine carcinoma. In : Rosen PP. Rosen's Breast Pathology, 3rd edition. Philadelphia : Lippincott Williams & Wilkins ; 2009. p.536-50.
 
澤木正孝ほか. 乳腺のアポクリン癌の臨床病理組織学的検討. 乳癌の臨床. 2003 ; 18 : 332-9.
Medical*Online
Durham JR, Fechner RE. The histologic spectrum of apocrine lesions of the breast. Am J Clin Pathol. 2000 ; 113 (Suppl 1) : S3-18.
 
O'Malley FP, Bane A. An update on apocrine lesions of the breast. Histopathology. 2008 ; 52 : 3-10.
PubMed
O'Malley FP, et al. Ductal carcinoma in situ of the breast with apocrine cytology : definition of a borderline category. Hum Pathol. 1994 ; 25 : 164-8.
PubMed
Tavassoli FA, Norris HJ. Intraductal apocrine carcinoma : a clinicopathologic study of 37 cases. Mod Pathol. 1994 ; 7 : 813-8.
PubMed
P.141 掲載の参考文献
Stuart JS, Laura CC. Biopsy Interpretation of the Breast. Philadelphia : Lippincott Williams & Wilkins, a Wolters Kluwer business ; 2009.
 
Fattaneh A. Tavassoli and Vincenzo Eusebi Tumors of the Mammary Gland. Washington : American Registry of Pathology ; 2009.
 
P.147 掲載の参考文献
Rosen PP. Secretory carcinoma. In : Rosen's Breast Pathology, 3rd ed. Philadelphia : Lippincott Williams & Wilkins ; 2009. p.563-70.
 
Ellis IO, et al. Secretory carcinoma. In : Tavassoli FA, Devilee P, editors. World Health Organization Classification of Tumours. Tumours of the Breast and Female Genital Organs. Lyon : IARC Press ; 2003. p.42-3.
 
林透. 分泌癌 (若年性癌). 黒住昌史, 森谷卓也編. 腫瘍鑑別診断アトラス 乳癌. 東京 : 文光堂 ; 2010. p.109-12.
 
大井恭代. 分泌癌. 土屋眞一ほか編. 乳腺病理カラーアトラス. 東京 : 文光堂 ; 2008. p.126-7.
 
日本乳癌学会編. 臨床・病理乳癌取扱い規約. 第16版. 東京 : 金原出版 ; 2008.
 
Gary L, et al. STAT 5a expression in various lesions of the breast. Virchows Arch. 2006 ; 448 : 165-71.
 
Strauss BL, et al. STAT 5a expression in the breast is maintained in secretory carcinoma, in contrast to other histological types. Hum Pathol. 2006 ; 37 : 586-92.
PubMed
Diallo R, et al. Secretory carcinoma of the breast : a distinct variant of invasive ductal carcinoma assessed by comparative genomic hybridization and immunohistochemistry. Hum Pathol. 2003 ; 34 : 1299-305.
PubMed
P.159 掲載の参考文献
Hull MT, et al. Glycogen-rich clear cell carcinoma of the breast ; A light and microscopic study. Cancer. 1981 ; 48 : 2003-9.
PubMed
Fisher ER, et al. Glycogen-rich clear cell breast cancer : With comments concerning other clear cell variants. Hum Pathol. 1985 ; 16 : 1085-90.
PubMed
Toikkanen S, Joensuu H. Glycogen-rich clear cell carcinoma of the breast ; A clinicopathologic flow cytometric study. Hum Pathol. 1991 ; 22 : 81-3.
PubMed
Tavassoli FA, Devilee P, editors. Pathology and Genetics of Tumors of the Breast and Female Genital Organs. World Health Organization Classification of Tumours.Lyon ; IARC Press ; 2003, p.46.
 
Sorensen FB, Paulsen SM. Glycogen-rich clear cell carcinoma of the breast : a solid variant with mucus. A light microscopic, immunohistochemical and ultrastructural study of a case. Histopathology. 1987 ; 11 : 857-69.
PubMed
Hull MT, Warfel KA. Glycogen-rich clear cell carcinoma of the breast cancer : A clinicopathologic and ultrastructural study. Am J Surg Pathol. 1986 ; 10 : 553-9.
 
Hayes MM, et al. Glycogen-rich clear cell carcinoma of the breast. A clinicopathologic study of 21 cases. Am J Surg Pathol. 1995 ; 19 : 904-11.
 
Fujino S, et al. Glycogen-rich clear cell carcinoma of the breast : A case report and review of the literature. Breast Cancer. 1996 ; 3 : 205-8
 
P.162 掲載の参考文献
秋山太, 坂元吾偉. 乳腺. 向井清ほか編. 外科病理学 II. 第4版. 東京 : 文光堂 ; 2006. p. 1173-226.
 
土屋眞一ほか. 乳管内病変の良悪性鑑別診断-乳頭状病変の鑑別点について-. 乳癌の臨床. 2008 ; 23 (5) : 393-401.
Medical*Online
森谷卓也. 乳管内病変の良・悪性鑑別診断-低乳頭構造～平坦型病変の鑑別点について-. 乳癌の臨床. 2008 ; 23 (6) : 525-30.
Medical*Online
荻谷朗子ほか. 非浸潤性乳管癌の発見契機別形態学的特徴. 乳癌の臨床. 2008 ; 23 (6) : 531-5.
Medical*Online
中村清吾. 全国アンケート調査結果からみた非浸潤性乳管癌の診断と治療-現状と今後の課題-. 乳癌の臨床. 2007 ; 22 (2) : 95-100.
Medical*Online
森谷卓也ほか. 乳管内乳頭腫 vs 非浸潤性乳管癌 (乳頭癌). 病理と臨床. 2008 ; 26 (11) : 1189-91.
Medical*Online
P.176 掲載の参考文献
Boecker W, et al. Usual ductal hyperplasia of the breast is a committed stem (progenitor) cell lesion distinct from atypical ductal hyperplasia and ductal carcinoma in situ. J Pathol. 2002 ; 198 : 458-67.
PubMed
Schnitt SJ, Collins LC. Intraductal proliferative lesions : usual ductal hyperplasia, atypical ductal hyperplasia, and ductal carcinoma in situ. In : Schnitt SJ, Collins LC, editors. Biopsy Interpretation of the Breast. Philadelphia : Lippincott Williams & Wilkins ; 2009. p.51-95.
 
P.181 掲載の参考文献
Page DL, et al. Atypical hyperplastic lesions of the breast. A long-term follow-up study. Cancer. 1985 ; 55 : 2698-708.
 
市原周. 異型乳管過形成・異型小葉過形成と非浸潤性乳管癌との鑑別. 黒住昌史, 森谷卓也編. 腫瘍鑑別診断アトラス 乳癌. 東京 : 文光堂 ; 2010. p.178-82.
 
Moinfer F. Intraductal proliferative lesions. In : Essentials of Diagnostic Breast Pathology. A Practical Approach. Berlin Heidelberg : Springer-Verlag ; 2007. p. 68-121.
 
P.185 掲載の参考文献
Tavassoli FA, Eusebi V. Papillary lesions of the breast. In : Silverberg SG, editor. Tumors the Mammary Gland, AFIP Atlas of Tumor Pathology Series 4. Washington DC : American Registry of Pathology ; 2009. p.101-16.
 
Rosen PP. Papilloma and related benign tumors. Rosen's Breast Pathology. 3rd ed. Philadelphia : Lippincott Williams & Wilkins ; 2009. p.85-136.
 
MacGrogan G, et al. Intraductal papillary neoplasms. In : Tavassoli FA, Devilee P, editors. World Health Organization Classification of Tumours, Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon : IARC Press ; 2003. p.76-80.
 
Tavassoli FA. Papillary lesions. Pathology of the Breast, 2nd ed. Stamford : Appleton & Lange ; 1999. p.325-71.
 
P.192 掲載の参考文献
Lee BJ, Tannenbaum NE. Inflammatory carcinoma of the breast. Surg Cynec Obstct. 1924 ; 39 : 380-95.
 
Ellis DL, Teitelbaum SI. Inflammatory carcinoma of the breast : a Pathologic definition. Cancer. 1974 ; 33 : 1045-7.
 
渡辺騏七郎. 炎症性乳癌-病理とその本体. 乳癌の臨床. 1992 ; 7 : 9-16.
 
Chang S, et al. Inflammatory breast carcinoma incidence and survival. The Surveillance, Epidermiology, and end results program of the national cancer institute, 1975-1992. Cancer. 1998 ; 82 : 2366-72.
 
泉雄勝. 炎症性乳癌-最近の視点から. 乳癌の臨床. 2006 ; 2 : 125-32.
 
岩田広治ほか. 炎症性乳癌全国アンケート結果. 乳癌の臨床. 2006 ; 2 : 201-8.
Medical*Online
西村令喜. 乳房温存療法後の炎症性乳癌型再発. 乳癌の臨床. 2002 ; 4 : 281-90.
Medical*Online
P.196 掲載の参考文献
Rosen PP. Paget's Disease of the Nipple. In : Rosen PP, editor. Rosen's Breast Pathology. 3rd ed. Philadelphia : Lippincott Williams&Wilkins, a Wolter Kluwer business ; 2009. p.621-36.
 
Eusebi V, Mai KT, Taranger-Charpin A. Tumours of the nipple. In : Tavassoli FA, Devilee P, editors. World Health Organization Classification of Tumours. Pathology & Genetics Tumours of the Breast and Female Genital Organs. Lyon : IARC Press, ; 2003. p.104-6.
 
Horii R, Akiyama F, Sakamoto G, et al. Spontaneous "Healing" of Breast Cancer. Breast Cancer. 2005 ; 12 : 140-4.
PubMed
P.202 掲載の参考文献
日本乳癌学会編. 乳癌診療ガイドライン 1. 薬物療法. 2010年版. 東京 : 金原出版 ; 2010. p.119-22.
 
Rosen PP. 36. Carcinoma of the male breast. In : Rosen PP, editor. Rosen's Breast Pathology. Philadelphia : Lippincott Williams & Wilkins ; 2009. p.787-803.
 
Tavassoli FA, Eusebi V. 17. Male breast lesions. In : Tavassoli FA, Eusebi V, editors. AFIP Atlas of Tumor Pathology 4th Series Fascicle 10. Tumors of the Mammary Gland. Washington DC : American Registry of Pathology ; 2009. p.371-89.
 
P.206 掲載の参考文献
Azzopardi JG. The benign epithelial hyperplasias and their interrelationships. In : Problems in Breast Pathology. London : WB Saunders Company Ltd ; 1979. p.25-38.
 
Rosen PP. Adenosis and microglandular adenosis. In : Rosen's Breast Pathology, 3rd ed. Philadelphia : Lippincott Williams & Wilkins ; 2009. p.161-86.
 
Eusebi V, et al. Microglandular adenosis, apocrine adenosis, and tubular carcinoma of the breast. An immunohistochemical comparison. Am J Surg Pathol. 1993 ; 17 (2) : 99-109.
PubMed
P.218 掲載の参考文献
Azzopargi JG, Salm R. Ductal adenoma of the breast : A lesion which can mimic carcinoma. J Pathol. 1984 ; 144 : 15-23.
 
Lemmie GA, Millis PR. Ductal adenoma of the breast-A review of fifteen cases. Hum Pathol. 1989 ; 20 : 903-8.
 
黒住昌史. 乳腺腫瘍の組織型と概念の解説. 1. Ductal adenoma. 乳癌の臨. 1997 ; 12 : 595-9.
 
有広光司. おさえておきたい組織型 乳管腺腫. 臨床と病理. 2008 : 26 : 1132-4.
 
川野輪香織, 黒住昌史. 乳管腺腫. 黒住昌史, 森谷卓也編. 腫瘍病理鑑別診断アトラス乳癌. 東京 : 文光堂 ; 2010. p.28-32.
 
Tavassoli FA, Devilee P, editors. Pathology and genenics of tumours of the breast and feamal genital organs. Lyon : IARC press ; 2003.
 
Tavassoli FA, Eusebi V, editors. Tumors of the Mammary Gland in AFIP Atlas of Tumor Pathology 4th Series. Washington : American Resgistry of Pathology ; 2009.
 
Rosen PP, editor. Rosen's breast pathology 3rd ed.Philadlphia : Wolters Kluwer ; 2009.
 
P.223 掲載の参考文献
Jones DB. Florid papillomatosis of the nipple ducts. Cancer. 1955 ; 8 : 315-9.
PubMed
Handley R, Thackray AC. Adenoma of the nipple. Br J Cancer. 1962 ; 16 : 187-94.
PubMed
日本乳癌学会編. 乳癌取扱い規約. 第16版. 東京 : 金原書店 ; 2008.
 
Rosen PP. Florid papillomatosis of the nipple. In : "Rosen's Breast Pathology". 3rd ed. Philadelphia : Lippincott Williams & Wilkins ; 2009. p.114-25.
 
Rosen PP. Syringomatous adenoma of the nipple. Am J Surg Pathol. 1983 ; 7 : 739-45.
PubMed
Oo KZ, Xiao PQ. Infiltrating syringomatous adenoma of the nipple : clinical presentation and literature review. Arch Pathol Lab Med. 2009 ; 133 : 1487-89.
PubMed
Moriya T, Kozuka Y, et al. The role of immunohistochemistry in the differential diagnosis of breast lesions. Pathology. 2009 ; 41 : 68-76.
PubMed
P.228 掲載の参考文献
日本乳癌学会編. 乳癌取扱い規約, 第16版. 東京 : 金原出版 ; 2008.
 
Bussolati G, et al. Benign epithelial proliferations. In : Tavassoli FA, Devilee P, editors. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. World Health Organizaion Classification of Tumours. Lyon : IARC Press ; 2003. p.81-5.
 
Hertel BF, et al. Breast adenomas. Cancer. 1976 ; 37 : 2891-905.
PubMed
James K, et al. Breast tumor of pregnancy ('lactating' adenoma). J Pathol. 1988 ; 156 : 37-44.
PubMed
Maiorano E, Albrizio M. Tubular adenoma of the breast. An immunohistochemical study of ten cases. Path Res Pract. 1995 ; 191 : 1222-30.
PubMed
Schnitt SJ, Collins LC. Fibroepithelial lesions. In : Biopsy interpretation of the breast. Philadelphia Wolsters Kluwer : Lippincott Williams & Wilkins ; 2009. p.153-80.
 
Slavin JL, et al. Nodular breast lesions during pregnancy and lactation. Histopathology. 1993 ; 22 : 481-5.
PubMed
Tavassoli FA. Bening lesions. In : Pathology of the Breast. 2nd ed. Stamford : Appleton & Lane ; 1999. p.115-204.
 
P.250 掲載の参考文献
Tavassoli FA, Eusebi V. Granular cell tumor. In : Silverberg SG, editor. Tumors the Mammary Gland, AFIP Atlas of Tumor Pathology Series 4. Washington DC : American Registry of Pathology ; 2009. p.281-3.
 
Rosen PP. Granular cell tumor. Rosen's Breast Pathology. 3rd ed. Philadelphia : Lippincott Williams & Wilkins ; 2009. p.859-62.
 
Drijkoningen M, et al. Mesenchymal tumours. In : Tavassoli FA, Devilee P, editors. World Health Organization Classification of Tumours, Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon : IARC Press ; 2003. p.89-98.
 
Tavassoli FA. Granular cell tumor. Pathology of the Breast, 2nd ed. Stamford : Appleton & Lange ; 1999. p.697-9.
 
Weiss SW, Goldblum JR. Granular cell tumor. Einzinger and Weiss's Soft tissue tumors. 5th ed. Philadelphia : Mosby Elsevier ; 2008. p.878-87.
 
Hitchcock MG, et al. Cutaneous granular cell angiosarcoma. J Cutan Pathol. 1994 ; 21 : 256-62.
PubMed
P.255 掲載の参考文献
Bellocq JP, Magro G. Fibroepithelial tumours. In : Tavassoli FA, Devilee P, editors. Tumours of the Breast and Female Genital Organs. Lyon : IARC Press ; 2003. p.103.
 
泉美貴. 過誤腫. 土屋眞一ほか編. 乳腺病理カラーアトラス. 東京 : 文光堂 ; 2008. p.150-1.
 
Rosen PP. Benign Mesenchymal Neoplasms. In : Rosen's Breast Pathology. Philadelphia : Lippincott Williams & Wilkins, a Wolters Kluwer business ; 2009. p.864-8.
 
Fisher CJ, et al. Mammary hamartoma-a review of 35 cases. Histopathology, 1992 ; 20 : 99-106.
PubMed
Charpin C, et al. Reappraisal of breast hamartomas. A morphological study of 41 cases. Pathol Res Pract. 1994 ; 190 : 362-71.
PubMed
Tse GMK, et al. Hamartoma of the breast : A clinicopathological review. J Clin Pathol. 2002 ; 55 : 951-4.
PubMed
Ravakhah K, et al. Hamartoma of the breast in a man : first case report. Breast J. 2001 ; 7 : 266-8.
 
Lee EH. Invasive ductal Carcinoma arising in a breast hamartoma : Two case reports and a review of the literature. Clin Radiol. 2003 ; 58 : 80-6.
 
Baron M, et al. Invasive lobular carcinoma in a breast hamartoma. Breast J. 2003 ; 9 : 246-8.
 
P.265 掲載の参考文献
Lamovec A, Wotherspoon A, et al. Malignant lymphoma and metastatic tumours. In : Tavassoli FA, Devilee P, editors. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon : IARC press ; 2003. p.107-9.
 
Swerdlow SH, Campo E, et al. editors. World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon : IARC ; 2008.
 
Rosen PP. Lymphoid and hematopoietic tumors. In : Rosen's Breast Pathology. 3rd ed. Philadelphia : Lippincott Williams & Wilkins ; 2009. p.959-83.
 
Talwalkar SS, Miranda RN, et al. Lymphomas involving the breast. A study of 106 cases comparing localized and disseminated neoplasms. Am J Surg Pathol. 2008 ; 32 : 1299-309.
PubMed
Wiseman C, Liao KT. Primary lymphoma of the breast. Cancer. 1972 ; 29 : 1705-12.
PubMed
de Jong D, Vasmel WL, et al. Anaplastic large-cell lymphoma in women with breast implants. JAMA. 2008 ; 300 : 2030-5.
PubMed
Domchek SM, Hecht JL, et al. Lymphomas of the breast. Primary and secondary involvement. Cancer. 2002 ; 94 : 6-13.
PubMed
Aozasa K, Ohsawa M, et al. Malignant lymphoma of the breast. Immunologic type and association with lymphocytic mastopathy. Am J Clin Pathol. 1992 ; 97 : 699-704.
PubMed
Hans CP, Weisenburger DD, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004 ; 103 : 275-82.
PubMed
P.274 掲載の参考文献
Rosen PP. Benign proliferative lesions of the male breast. In : Rosen PP, editor. Rosen's Breast Pathology. Philadelphia : Lippincott Williams & Wilkins ; 2009. p.775-86.
 
Tavassoli FA, Eusebi V. Male breast lesions. In : Tavassoli FA, Eusebi V, editors. AFIP Atlas of Tumor Pathology 4th Series Fascicle 10. Tumors of the Mammary Gland. Washington DC : American Registry of Pathology ; 2009. p.371-89.
 
P.278 掲載の参考文献
森谷卓也. 副乳. 黒住昌史, 森谷卓也編. 腫瘍病理鑑別診断アトラス 乳癌. 東京 : 文光堂 ; 2010. p.174-6.
 
Rosen PP. Abnormalities of Mammary Growth and Development. In : Rosen PP. Rosen's Breast Pathology, 3rd ed. Philadelphia : Lippincott Williams & Wilkins ; 2007. p.26-32.
 
Rosen PP. Unusual clinical presentation of carcinoma. In : Rosen PP. Rosen's Breast Pathology, 3rd ed. Philadelphia : Lippincott Williams & Wilkins ; 2007. p.721-58.
 
van der Putte SC. Anogenital Sweat glands. Histology and pathology of a gland that may mimic mammary glands. Am J Dermatopathol. 1991 ; 13 : 557-67.
PubMed
van der Putte SC. Mammary-like glands of the vulva and their disorders. Int J Gynecol Pathol. 1994 ; 13 : 150-60.
PubMed
P.287 掲載の参考文献
Brogi E. Benign and malignant spindle cell lesions of the breast. Semin Diagn Pathol. 2004 ; 21 : 57-64.
PubMed
Benign fibroblastic/myofibroblastic proliferations. In : Weiss SW, Goldblum JR, editors. Enzinger & Weiss's Soft Tissue Tumors. 2008. p.175-225.
 

4章 病理検体の取り扱い

P.299 掲載の参考文献
Collage of American Pathologists. Protocol for the Examination of Specimens from Patients with Invasive Carcinoma of the Breast. 2003. p.1515-38.
 

5章 症例の実際

P.310 掲載の参考文献
Tavassoli FA, Devilee P. Granular cell tumor. Tumours of the breast and female genital organs. Lyon : IARC Press ; 2003. p.94.
 
P.312 掲載の参考文献
Rosen PP. Florid papillomatosis of the nipple. In : "Rosen's Breast Pathology". 3rd ed. Philadelphia : Lippincott Williams & Wilkins ; 2009. p.114-25.
 
Ishii N, Kusuhara M, et al. Adenoma of the nipple in a Japanese man. Clin Exp Dermatol. 2007 ; 32 : 448-9.
 
Tan PH, Aw MY, et al. Cytokeratins in papillary lesions of the breast : is there a role in distinguishing intraductal papilloma from papillary carcinoma in situ? Am J Surg Pathol. 2005 ; 29 : 625-32.
 

書評

最近チェックした商品履歴

Loading...